CLINICAL_TRIALS
trial_result
· 2015-03-31
Clinical Trial Update: Dasotraline SEP360-105 Pediatric PK/PD Study [Phase 1]
Summary
This update notes the completion of a Phase 1 pediatric PK/PD study of dasotraline SEP360-105 in children with ADHD.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Pediatric Attention Deficit Hyperactivity Disorder | Phase 1 | Status: COMPLETED